High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks. (Q35138116)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

1 reference

1 reference

1 reference

Ji B

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Jamet P

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sow S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Perani EG

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Traore I

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Grosset JH

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

1953-1956

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients

6 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164043

Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164043

Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164043

Classification of leprosy according to immunity. A five-group system

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164043

Drug resistance in leprosy--a review.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164043

Detection of persisting Mycobacterium leprae by inoculation of the neonatally thymectomized rat.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164043

Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164043

Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164043

The bactericidal effect of rifampicin on M. leprae in man: a) single doses of 600, 900 and 1200 mg; and b) daily doses of 300 mg.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164043

Relapses after a single dose of rifampin in skin-smear negative multibacillary patients after dapsone monotherapy.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164043

Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae

27 September 2018

1 reference

12 December 2020

Activity of ofloxacin against Mycobacterium leprae in the mouse

1 reference

12 December 2020

Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy

1 reference

12 December 2020

Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen. Marchoux Chemotherapy Study Group

1 reference

12 December 2020

Determination of the minimal effective dosages of ofloxacin and sparfloxacin against M. leprae in the mouse foot pad system

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.41.9.1953

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303392%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference